Rural-Urban Differences in Diabetes Care and Control in 42 Low- and Middle-Income Countries: A Cross-sectional Study of Nationally Representative Individual-Level Data.
Journal
Diabetes care
ISSN: 1935-5548
Titre abrégé: Diabetes Care
Pays: United States
ID NLM: 7805975
Informations de publication
Date de publication:
01 09 2022
01 09 2022
Historique:
received:
10
11
2021
accepted:
18
05
2022
pubmed:
1
7
2022
medline:
9
9
2022
entrez:
30
6
2022
Statut:
ppublish
Résumé
Diabetes prevalence is increasing rapidly in rural areas of low- and middle-income countries (LMICs), but there are limited data on the performance of health systems in delivering equitable and effective care to rural populations. We therefore assessed rural-urban differences in diabetes care and control in LMICs. We pooled individual-level data from nationally representative health surveys in 42 countries. We used Poisson regression models to estimate age-adjusted differences in the proportion of individuals with diabetes in rural versus urban areas achieving performance measures for the diagnosis, treatment, and control of diabetes and associated cardiovascular risk factors. We examined differences across the pooled sample, by sex, and by country. The pooled sample from 42 countries included 840,110 individuals (35,404 with diabetes). Compared with urban populations with diabetes, rural populations had ∼15-30% lower relative risk of achieving performance measures for diabetes diagnosis and treatment. Rural populations with diagnosed diabetes had a 14% (95% CI 5-22%) lower relative risk of glycemic control, 6% (95% CI -5 to 16%) lower relative risk of blood pressure control, and 23% (95% CI 2-39%) lower relative risk of cholesterol control. Rural women with diabetes had lower achievement of performance measures relating to control than urban women, whereas among men, differences were small. Rural populations with diabetes experience substantial inequities in the achievement of diabetes performance measures in LMICs. Programs and policies aiming to strengthen global diabetes care must consider the unique challenges experienced by rural populations.
Identifiants
pubmed: 35771765
pii: 147155
doi: 10.2337/dc21-2342
pmc: PMC9472489
doi:
Banques de données
figshare
['10.2337/figshare.20063189']
Types de publication
Journal Article
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1961-1970Subventions
Organisme : NIDDK NIH HHS
ID : P30 DK092926
Pays : United States
Organisme : NIDDK NIH HHS
ID : K23 DK125162
Pays : United States
Organisme : NCATS NIH HHS
ID : KL2 TR003143
Pays : United States
Organisme : NIDDK NIH HHS
ID : T32 DK007028
Pays : United States
Organisme : NCATS NIH HHS
ID : KL2 TR002542
Pays : United States
Informations de copyright
© 2022 by the American Diabetes Association.
Références
Lancet Diabetes Endocrinol. 2018 Mar;6(3):208-222
pubmed: 29371076
PLoS One. 2017 Oct 2;12(10):e0184264
pubmed: 28968435
Lancet. 2016 Feb 20;387(10020):811-6
pubmed: 26299185
Lancet Healthy Longev. 2021 Jun;2(6):e340-e351
pubmed: 35211689
Am J Public Health. 2016 Jan;106(1):74-8
pubmed: 26696288
Crit Pathw Cardiol. 2013 Jun;12(2):53-8
pubmed: 23680809
Lancet. 2020 Oct 17;396(10258):1160-1203
pubmed: 33069325
Int J Epidemiol. 2010 Apr;39(2):417-20
pubmed: 19926667
Diabetes Care. 2011 Sep;34(9):1980-5
pubmed: 21816976
Diabetes Res Clin Pract. 2014 May;104(2):206-13
pubmed: 24507869
Lancet Glob Health. 2014 May;2(5):e285-92
pubmed: 24818084
J Am Coll Cardiol. 2021 Mar 23;77(11):1480-1481
pubmed: 33736831
Diabetes Res Clin Pract. 2013 Jun;100(3):306-29
pubmed: 23375230
Clin Chem. 2011 Jun;57(6):e1-e47
pubmed: 21617152
Nature. 2019 May;569(7755):260-264
pubmed: 31068725
Diabetes Res Clin Pract. 2008 Aug;81(2):250-7
pubmed: 18495287
Lancet Glob Health. 2021 Nov;9(11):e1539-e1552
pubmed: 34562369
Bull World Health Organ. 2011 Mar 1;89(3):172-83
pubmed: 21379413
J Nutr. 2015 Feb;145(2):352-7
pubmed: 25644358
Lancet Diabetes Endocrinol. 2018 Oct;6(10):798-808
pubmed: 30170949
Lancet. 2016 Jan 2;387(10013):61-9
pubmed: 26498706
Diabetologia. 2021 May;64(5):954-962
pubmed: 33483763
Diabetes Res Clin Pract. 2015 Feb;107(2):203-23
pubmed: 25529849
Lancet Diabetes Endocrinol. 2017 Nov;5(11):839
pubmed: 29082880
Diabetes Care. 2021 Aug;44(8):1766-1773
pubmed: 34127495
Glob Health Action. 2021 Jan 1;14(1):1975920
pubmed: 34569443
Lancet Diabetes Endocrinol. 2021 Jun;9(6):325-327
pubmed: 33862005
Lancet. 2016 Apr 9;387(10027):1513-1530
pubmed: 27061677
Lancet Public Health. 2017 Sep;2(9):e411-e419
pubmed: 29253412
Lancet Diabetes Endocrinol. 2017 Aug;5(8):622-667
pubmed: 28688818
Lancet. 2021 Sep 25;398(10306):1133-1146
pubmed: 34469765
J Community Health. 2010 Aug;35(4):365-74
pubmed: 20386968
Lancet Diabetes Endocrinol. 2016 Nov;4(11):903-912
pubmed: 27727123
Circulation. 2013 Apr 9;127(14):1493-502, 1502e1-8
pubmed: 23481623
Lancet. 2021 Dec 19;396(10267):2019-2082
pubmed: 33189186
Ann Intern Med. 2014 Nov 18;161(10):681-9
pubmed: 25402511
Curr Diab Rep. 2015 Sep;15(9):64
pubmed: 26209940
PLoS Med. 2019 Mar 1;16(3):e1002751
pubmed: 30822339
Annu Rev Public Health. 2016;37:395-412
pubmed: 26735432